Original article can be found here.
SAN DIEGO, Sept. 26, 2016 /PRNewswire/ — Biocom, the association representing the California life science community, today announced the winners of its inaugural Life Science Catalyst Awards, presented in conjunction with the San Diego Venture Group.
The program celebrates up-and-coming academics, entrepreneurs, investors, corporate leaders and business advisers who are making a lasting and positive mark on San Diego’s life science industry before reaching their 40th birthday.
“The recipients of the Life Science Catalyst Awards represent the future of our biotechnology industry — a future that’s extremely exciting,” said Joe Panetta, president and CEO of Biocom. “These inspiring individuals are leading the growth of life sciences in San Diego and beyond, and are actively shaping what our industry will look like tomorrow. Biocom congratulates them for their achievements.”
Biocom selected the 10 winners from an impressive pool of nominees that included professionals from a wide range of life science organizations, from publicly held biotech companies to universities and consultancies. Each nominee was vetted by a committee of Biocom and San Diego Venture Group board and committee members, evaluating factors such as innovation, leadership and vision. In addition, 10 nominees received honorable mentions.
Listed in alphabetical order, the Biocom Life Science Catalyst Award winners are:
• Phil Baran, professor and Darlene Shiley Chair in Chemistry, The Scripps Research Institute
• Martyn Gross, chief executive officer, Clarify Medical
• Tony Grover, vice president, business development, Banyan Biomarkers
• Susie Harborth, general partner, BioInnovation Capital, managing director, BioLabs San Diego
• Michael Heltzen, chief executive officer, AllSeq
• Rob Knight, faculty director, Center for Microbiome Innovation Pediatrics, computer science & engineering, UCSD
• Dena Marrinucci, vice president of research, Salveo Dx
• Mike Milligan, principal, life science department, Barney & Barney
• Ed Truitt, co-founder and chief executive officer, Lubris BioPharma
• Ashley Van Zeeland, chief technology officer, Human Longevity